Expertise in
1
conditions

Dr. Tory P. Sullivan

Dermatology | Public Health and Preventive Medicine
Tory Sullivan MD PA
16100 Ne 16th Ave, Suite A, 
North Miami Beach, FL 
Accepting New Patients
Expertise in
1
conditions
Tory Sullivan MD PA
16100 Ne 16th Ave, Suite A, 
North Miami Beach, FL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Tory Sullivan is a Dermatologist and a Public Health and Preventive Medicine provider in North Miami Beach, Florida. Dr. Sullivan is highly rated in 1 condition, according to our data. His top areas of expertise are Comedones, Contact Dermatitis, Autoerythrocyte Sensitivity, and Gardner-Diamond Syndrome. Dr. Sullivan is currently accepting new patients.

His clinical research consists of co-authoring 1 peer reviewed article and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Dermatology
Public Health and Preventive Medicine
Licenses
Obesity Medicine in FL
Languages Spoken
English
Spanish
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Florida Blue
  • EPO
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Oscar
  • EPO
  • HMO
  • PPO

Locations

TORY SULLIVAN MD PA
16100 Ne 16th Ave, Suite A, North Miami Beach, FL 33162

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
Enrollment Status: Completed
Publish Date: June 15, 2025
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Randomized, Double-blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate to Severe Atopic Dermatitis
A Randomized, Double-blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: November 30, 2022
Intervention Type: Biological, Other
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: May 04, 2021
Intervention Type: Drug, Biological
Study Phase: Phase 2
A Phase 3, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of Cortexolone 17α-Propionate (CB-03-01) Cream, 1% Applied Twice Daily for 12 Weeks in Subjects With Facial Acne Vulgaris
A Phase 3, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of Cortexolone 17α-Propionate (CB-03-01) Cream, 1% Applied Twice Daily for 12 Weeks in Subjects With Facial Acne Vulgaris
Enrollment Status: Completed
Publish Date: November 20, 2020
Intervention Type: Drug
Study Phase: Phase 3
A Randomized, Double-Blind, Active- and Vehicle-Controlled Study to Compare the Efficacy and Safety of Products S2G6T-1, S2G6T-2, S2G6T-3 and S2G6T-4 in Patients With Symptomatic Inflammatory Interdigital Tinea Pedis
A Randomized, Double-Blind, Active- and Vehicle-Controlled Study to Compare the Efficacy and Safety of Products S2G6T-1, S2G6T-2, S2G6T-3 and S2G6T-4 in Patients With Symptomatic Inflammatory Interdigital Tinea Pedis
Enrollment Status: Terminated
Publish Date: November 18, 2020
Intervention Type: Drug
Study Phase: Phase 2
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Enrollment Status: Completed
Publish Date: December 13, 2017
Intervention Type: Drug
Study Phase: Phase 2
View 5 Less Clinical Trials

1 Total Publications

Efficacy and safety of a novel topical minocycline foam for the treatment of moderate to severe acne vulgaris: A phase 3 study.
Efficacy and safety of a novel topical minocycline foam for the treatment of moderate to severe acne vulgaris: A phase 3 study.
Journal: Journal of the American Academy of Dermatology
Published: April 18, 2019
Similar Doctors
Expertise in
30
conditions
Dr. Antonella Tosti
Dermatology
Expertise in
30
conditions
Dr. Antonella Tosti
Dermatology

University Of Miami

1611 Nw 12 Ave, 
Miami, FL 
 (9.6 mi)
Languages Spoken:
English, Italian
See accepted insurances
Accepting New Patients

Antonella Tosti is a Dermatologist in Miami, Florida. Dr. Tosti is highly rated in 30 conditions, according to our data. Her top areas of expertise are Autosomal Recessive Hypotrichosis, Alopecia Areata, Ringworm, and Splinter Hemorrhages. Dr. Tosti is currently accepting new patients.

Expertise in
25
conditions
Dr. Gil Yosipovitch
Dermatology
Expertise in
25
conditions
Dr. Gil Yosipovitch
Dermatology

University Of Miami

1601 Nw 12th Ave, 
Miami, FL 
 (9.7 mi)
Languages Spoken:
English, Hebrew
See accepted insurances
Accepting New Patients
Offers Telehealth

Gil Yosipovitch is a Dermatologist in Miami, Florida. Dr. Yosipovitch is highly rated in 25 conditions, according to our data. His top areas of expertise are Prurigo Nodularis, Atopic Dermatitis, Stasis Dermatitis and Ulcers, and Lichen Simplex Chronicus. Dr. Yosipovitch is currently accepting new patients.

Expertise in
16
conditions
Dr. Mariya I. Miteva
Dermatology
Expertise in
16
conditions
Dr. Mariya I. Miteva
Dermatology

University Of Miami

1611 Nw 12 Ave, 
Miami, FL 
 (9.6 mi)
Languages Spoken:
English, Bulgarian, German
See accepted insurances
Accepting New Patients
Offers Telehealth

Mariya Miteva is a Dermatologist in Miami, Florida. Dr. Miteva is highly rated in 16 conditions, according to our data. Her top areas of expertise are Autosomal Recessive Hypotrichosis, Graham-Little-Piccardi-Lassueur Syndrome, Dissecting Cellulitis of the Scalp, and Splinter Hemorrhages. Dr. Miteva is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Sullivan's expertise for a condition
ConditionClose
      View All 40 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile